Maybe you’re thinking: “Okay, Forest Labs, you’re touting how great Viibryd is. So, when am I going to see it? Feels like you’re teasing me and it’s terribly unpleasant.” Go ahead, let it rip. A good rant can be healthy.
Nothing makes me angrier than suffering people having to wait for relief. And that’s what’s going on with the availability of Viibryd.
After fielding more email questions regarding Viibryd’s launch, I did some digging, and guess what I found. Um, not much.
“Second half of 2011?”
The best bit of info I could come up with was this blurb from a Forest Labs press release dated 2.22.11…
Forest plans to launch Viibryd in the U.S. during the second half of 2011. Viibryd is expected to retain market exclusivity until March 2020 including full patent term extension of its composition of matter patent and anticipated pediatric exclusivity. Other patents may further extend this period.
I might also add I called two pharmacies and neither pharmacist knew a thing.
Keep us informed
If you hear anything regarding Viibryd’s launch, please let me know in a comment or via the contact form. I’ll get the info on Chipur.
Be sure to read Viibryd: A new antidepressant, but anything exciting?
And check-out the hundreds of Chipur titles.
